Oxidative stress induced in pathologies: The role of antioxidants

Urban, 1991, NFkB contacts DNA by a heterodimer of p50 and p65 subunit, EMBO J, 10, 1817, 10.1002/j.1460-2075.1991.tb07707.x Urban, 1990, The 65 kDa subunit of NFkB is a receptor for IkB and a modulator of DNA-binding specificity, Genes Dev, 4, 1975, 10.1101/gad.4.11.1975 Bauerle, 1988, Activation of DNA-binding activity in an apparently cytoplasmic precursor of NFkB transcription factor, Cell, 53, 211, 10.1016/0092-8674(88)90382-0 Sen, 1986, Inducibility of k immunoglobulin enhancer-binding protein NFk by a post-translational mechanism, Cell, 47, 921, 10.1016/0092-8674(86)90807-X Iwasaki, 1992, Herbymicin A blocks IL-1-induced NFkB DNA-binding activity in lymphoid cell lines, FEBS Lett, 298, 240, 10.1016/0014-5793(92)80067-Q Schreck, 1992, Dithiocarbamate as potent inhibitors of nuclear factor kB activation in intact cells, J Exp Med, 75, 1181, 10.1084/jem.175.5.1181 Griffin, 1989, Activation of HIV gene expression during monocyte differentiation by induction of NFkB, Nature, 339, 70, 10.1038/339070a0 Kehler, 1989, Free radicals as mediators of tissue injury and disease, Crit Rev Toxicol, 23, 21 Moolenaar, 1995, Lysophosphatidic acid, a multifunctional phospholipid messenger (review), J Biol Chem, 270, 12949, 10.1074/jbc.270.22.12949 Ross, 1979, The pathogenesis of atherosclerosis (second of two parts) (review), N Engl J Med, 295, 420, 10.1056/NEJM197608192950805 Natarajan, 1995, Oxidized low density lipoprotein-mediated activation ofphospho-lipase D in smooth muscle: a possible role in cell proliferation and atherogenesis, J Lipid Res, 36, 2005, 10.1016/S0022-2275(20)41118-6 Draper, 1990, A review on recent studies on the metabolism of exogenous and endogenous malondialdehyde, Xenobiotica, 20, 901, 10.3109/00498259009046905 Halliwell, 1989, Free radicals in biology and medicine Kergonou, 1988, Immunogenicity of proteins reacted with malonic dialdehyde (MDA), Adv Biosci, 71, 121 Sato, 1979, Lipid peroxide level in plasma of diabetic patients, Biochem Med, 21, 104, 10.1016/0006-2944(79)90061-9 Esterbauer, 1990, Biochemical, structural and functional properties of oxidized lowdensity lipoproteinss, Chem Res Toxicol, 3, 77, 10.1021/tx00014a001 Plachta, 1992, Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries, Clin Chin Acta, 211, 101, 10.1016/0009-8981(92)90109-4 Kawamoto, 1986, Serum lipid peroxide level in apoplexia, J Clin Biochem Nutr, 1, 1, 10.3164/jcbn.1.1 Rouach, 1997, Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology, Hepatology, 2, 351, 10.1002/hep.510250216 Practico, 1992, Hydrogen peroxide triggers activation of human platelets selectively exposed to non aggregating con-centrations of arachidonic acid and collagen, J Lab Clin Med, 119, 364 Miller, 1985, Endothelial cell prostayclin production induced by activated neutrophils, J Biol Chem, 60, 1006, 10.1016/S0021-9258(20)71200-7 Tien, 1982, Comparative aspects of several model lipid peroxidation systems, 23 Smith, 1990, Cholesterol oxidation, 129 Steinberg, 1989, Beyond cholesterol: modifications of low-density lipoprotein that increase its artherogenicity, N Engl J Med, 320, 915, 10.1056/NEJM198904063201407 Galle, 1995, Impairment of endothelium-dependant dilation in rabbit renal arteries by oxi-dized lipoprotein (a): role of oxygen-derived radicals, Circulation, 92, 1582, 10.1161/01.CIR.92.6.1582 Kasai, 1986, Formation of 8-hydroxyguanine in cellular DNA by agents producing oxygen radicals and evidence for its repair, Carcinogenesis, 8, 1849, 10.1093/carcin/7.11.1849 Ames, 1983, Dietary carcinogens and anticarcinogens, Science, 221, 1256, 10.1126/science.6351251 Floyd, 1990, The role of 8-hydroxyguanosine in carcinogenesis, Carcinogenesis, 11, 1447, 10.1093/carcin/11.9.1447 Fraga, 1990, Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine, 87, 4533 Dandona, 1996, Oxidative DNA damage diabetes mellitus, Lancet, 347, 444, 10.1016/S0140-6736(96)90013-6 Sipowicz, 1997, Increased oxidative DNA dam-age and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus, Am J Pathol, 4, 933 Chung, 1991, An endonuclease activity of Escherichia coli that specifically removes 8-hydroxyguanine residues from DNA, Mutat Res, 254, 1, 10.1016/0921-8777(91)90035-N Domigan, 1995, Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils, Biol Chem, 270, 16542, 10.1074/jbc.270.28.16542 Lewisch, 1995, Determination of 2-oxohistidine by amino acid analysis, Ann Biochem, 231, 440, 10.1006/abio.1995.9974 Wiseman, 1996, Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer, Biochem J, 313, 17, 10.1042/bj3130017 Berliner, 1996, The role of oxidized lipoproteins in atherogenesis, Free Rad Biol Med, 20, 707, 10.1016/0891-5849(95)02173-6 Stadtman, 1992, Protein oxidation and aging, Science, 257, 1220, 10.1126/science.1355616 Moncada, 1991, Nitric oxide: physiology, physiopathology and pharmacology (review), Pharmacol Rev, 43, 109 Bredt, 1990, Isolation of nitric oxide synthase, a calmodulin requiring enzyme, 87, 682 Stuehr, 1991, Purification and characterization of the cytokine induced macrophage nitric oxide synthase: an FAD and FMN containing flavoprotein, 88, 7773 Forstermann, 1994, Biochemistry and molecular biology of nitric oxide synthases (review), Arzneimittel-forshung, 44, 402 Sessa, 1994, The nitric oxide synthase family of proteins, J Vas Res, 31, 131, 10.1159/000159039 Halliwell, 1992, Free radicals,antioxidants and human disease: where are we now?, J Lab Clin Med, 119, 598 Ursini, 1986, Phospholipid hydroper-oxidase glutathione peroxidase, Int J Tiss Reac, 8, 99 Janero, 1991, Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis, Free Rad Biol Med, 1, 129, 10.1016/0891-5849(91)90193-7 De Leve, 1991, Glutathione metabolism and its role in hepatotoxicity, Pharmacol Ther, 52, 287, 10.1016/0163-7258(91)90029-L Deneke, 1989, Regulation of cellular glutathione, Lung Cell Mol Physiol, 1, L163, 10.1152/ajplung.1989.257.4.L163 Kaplowitz, 1985, The regulation of hepatic glutathione, Annu Rev Pharmacol Toxicol, 25, 715, 10.1146/annurev.pa.25.040185.003435 Loguercio, 1992, Alteration of erythrocyte glutathione, cysteine and glutathione syn-thetase in alcoholic and non-alcoholic cirrhosis, Scand J Clin Lab Invest, 52, 207, 10.3109/00365519209088787 Shigesawa, 1992, Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease, J Gastroenterol Hepatol, 7, 7, 10.1111/j.1440-1746.1992.tb00926.x Staal, 1992, Intracellular glutathione levels in T-cell subsets decrease in HIV-infected individuals, AIDS Res Hum Retroviruses, 8, 305, 10.1089/aid.1992.8.305 Holroyd, 1993, Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment, Thorax, 48, 985, 10.1136/thx.48.10.985 Mihm, 1991, Inhibition of HIV-1 replication and NFkappaB activity by cysteine and cysteine derivatives, AIDS, 5, 497, 10.1097/00002030-199105000-00004 Pachter, 1991, Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome, Chest, 100, 1397, 10.1378/chest.100.5.1397 Grigg, 1993, Bronchoalveolar lavage fluid glutathione in incubated premature infants, Arch Dis Child, 69, 49, 10.1136/adc.69.1_Spec_No.49 Smith, 1993, Increased levels of glutathione in bronchalveolar lavage from patients with asthma, Am Rev Respir Dis, 147, 1461, 10.1164/ajrccm/147.6_Pt_1.1461 Jenner, 1994, Oxidative damage in neurodegenerative disease, Lancet, 344, 796, 10.1016/S0140-6736(94)92347-7 Sian, 1994, Glutathione-related enzymes in brain in Parkinson's disease, Ann Neurol, 36, 356, 10.1002/ana.410360306 Hoshida, 1994, Gamma-glutamylcysteine ethyl ester for myocardial protection in dogs during ischemic and reperfusion, J Am Coll Cardiol, 24, 1391, 10.1016/0735-1097(94)90125-2 Forman, 1988, Glutathione redox pathway and perfusion injury, Circulation, 78, 202, 10.1161/01.CIR.78.1.202 Duruibe, 1989, Effect of cyclosporin on rat liver and kidney glutathione content, Pharmacology, 39, 205, 10.1159/000138599 Wang, 1994, Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo, Transplantation, 58, 940, 10.1097/00007890-199410270-00014 Amano, 1994, Salutary effect of reduced glutathione on renal function in coronary artery bypass operation, J Am Coll Surg, 179, 714 Julius, 1994, Glutathione and morbidity in a community-based sample of elderly, J Clin Epidemiol, 47, 1021, 10.1016/0895-4356(94)90117-1 Lang, 1992, Low blood glutathione in healthy aging adults, J Lab Clin Med, 120, 720 Flagg, 1994, Dietary glutathione intake and the risk of oral and pharyngeal cancer, Am J Epidemiol, 139, 453, 10.1093/oxfordjournals.aje.a117028 Tew, 1994, Glutathione associated enzymes in anticancer drug resistance. Perspectives in cancer research, Cancer Res, 54, 4313 Aw, 1991, Oral glutathione increases tissue glutathione in vivo, Chem Biol Interact, 80, 89, 10.1016/0009-2797(91)90033-4 Grattagliano, 1995, Disposition of glutathione monoethyl ester in the rat: glutathione ester is a slow release of extracellular glutathione, 272, 484 Lomaestro, 1995, Glutathione in health and disease: pharmacotherapeutic issues, Ann Pharmacother, 29, 1263, 10.1177/106002809502901213 Holmgren, 1985, Thioredoxin, Annu Rev Biochem, 254, 237, 10.1146/annurev.bi.54.070185.001321 Bjornstedt, 1994, The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase, J Biol Chem, 269, 29382, 10.1016/S0021-9258(18)43889-6 Bjornstedt, 1992, Selenoglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase, J Biol Chem, 267, 8030, 10.1016/S0021-9258(18)42403-9 Homgren, 1998, Redox regulation by the thioredoxin and glutaredoxin systems, 229 Holmgren, 1995, Glutaredoxin, Methods Enzymol, 252, 283, 10.1016/0076-6879(95)52031-7 Weischel, 1996, Crystal structures of reduced, oxidized and mutated human thioredoxins: evidence for a regulatory homodimer, Structure, 4, 735, 10.1016/S0969-2126(96)00079-2 Cabiscol, 1996, The phosphate activity of carbonic anhydrase III is reversibly regulated by glutathionylation, 93, 4170 Staal, 1990, Intracellular thiol regulate activation of nuclear factor kappa-B and transcription of humanimmunodeficiency virus, 87, 9946 Malmezat, 1998, Metabolism of cysteine is modified during the acute phase of sepsis in rats, J Nutr, 1, 97, 10.1093/jn/128.1.97 Huxtable, 1992, Physiological actions of taurine, Physiol Rev, 72, 101, 10.1152/physrev.1992.72.1.101 Aruoma, 1988, The antioxidant action of taurine, hypotaurine and their metabolic A precursors, Biochem J, 256, 251, 10.1042/bj2560251 Tadolini, 1995, Effects of taurine and hypotaurine on lipid peroxidation, Biochem Biophys Res Commun, 213, 820, 10.1006/bbrc.1995.2203 You, 1998, Effects of taurine supplementation on lipid peroxidation, blood glucose and blood lipid metabolism in streptozotocin-induced diabetic rats, Adv Exp Med Biol, 1, 163, 10.1007/978-1-4899-0117-0_21 Raschke, 1995, Taurine protects the heart from neutrophil-induced reperfusion injury, Free Rad Biol Med, 4, 461, 10.1016/0891-5849(95)00044-X Benedetti, 1991, Effects of aging on the content in sulfur-containing amino acids in rat brain, J Neural Transm Gen Sect, 3, 191, 10.1007/BF01250705 Sen, 1998, Therapeutic potential of the antioxidant and redox properties of alpha-lipoic acid, 251 Packer, 1995, Alpha-lipoic acid as a biological antioxidant, Free Rad Biol Med, 19, 227, 10.1016/0891-5849(95)00017-R Matsugo, 1995, Elucidation of antioxidant activity of dihydrolipoic acid toward hydroxyl radical using a novel hydroxyl generator NP-III, Biochem Mol Biol Int, 37, 375 Jocelyn, 1967, The standard redox potential of cysteine-cystine from the thiol-disulphide exchange reaction with glutathione and lipoic acid, Eur J Biochem, 2, 327, 10.1111/j.1432-1033.1967.tb00142.x Podda, 1994, Alpha-Lipoic acid supplementation prevents symptoms of vitamin E deficiency, Biochem Biophys Res Commun, 204, 98, 10.1006/bbrc.1994.2431 Busse, 1992, Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo, Arz Forsh, 42, 829 Sen, 1996, Antioxidant and redox regulation of gene transcription, FASEB J, 10, 709, 10.1096/fasebj.10.7.8635688 Baur, 1991, Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication, Klin Wochen-schr, 69, 722, 10.1007/BF01649442 Frei, 1998, Relative importance of vitamin E in antiperoxidative defences in human blood and low-density lipoprotein (LDL), 131 Packer, 1979, Direct observation of a free radical interaction between vitamin E and C, Nature, 278, 737, 10.1038/278737a0 Bode, 1990, Spontaneous decay of oxidized ascorbic acid (dehydro-L-ascorbic acid) evaluated by high-pressure liquid chromatography, Clin Chem, 36, 1807, 10.1093/clinchem/36.10.1807 Reaven, 1995, Effects of vita-min E on susceptibility of low-density lipoprotein and low-density lipoprotein subfraction to oxidation and or protein glycation in NIDDM, Diabetes Care, 18, 807, 10.2337/diacare.18.6.807 Nyssoner, 1994, Increase in oxidation resistance of artherogenic serum lipoprotein following antioxidant supplementation: a ran-domized double-blind placebo-controlled clinical trial, Eur J Clin Nutr, 48, 633 Stampfer, 1993, Vitamin consumption and the risk of coronary disease in women, N Engl J Med, 328, 1444, 10.1056/NEJM199305203282003 Boogaerts, 1984, Protective effect of vitamin E on immune triggered, granulocyte mediated endothelial injury, Thromb Haemost, 1, 89 Hennig, 1989, Protective effects of vitamin E in age-related endothelial cell injury, Int J Vitam Nutr Res, 2, 273 Janero, 1989, Oxidative injury to myocardial membrane: direct modulation by endogenous alphatoco-pherol, J Mol Cell Cardiol, 11, 1111, 10.1016/0022-2828(89)90689-5 Witting, 1999, Assessment of prooxidant activity of vitamin E in human low-density lipoprotein in plasma, 362, 10.1016/S0076-6879(99)99036-5 Beno, 1994, The activ-ity of Cu/Zn-superoxide dismutase and catalase of gastric mucosa in chronic gastritis, and the effect of alpha-tocopherol, Bratisl Lek Listy, 1, 9 Janero, 1988, Myocardial vitamin E (alpha-toco-pherol) contents of spontaneously hypertensive and Wistar-Kyoto normotensive rats, Int J Vitam Nutr Res, 3, 292 Gey, 1989, Inverse correlation of vitamin E and ischemic heart disease, Int J Vitam Nutr Res, 21, 224 Mezes, 1986, Studies of the blood lipid peroxide status and vitamin E levels in patients with chronic active hepatitis and alcoholic liver disease, Int J Clin Pharmacol Res, 14, 333 Martensson, 1993, Glutathione ester delays the onset of scurvy in ascorbate-deficient guinea pigs, 90, 317 Nowak, 1989, Ascorbic acid inhibits poly-morphonuclear leukocytes influx to the place of inflamma-tion-possible protection of lung from phagocyte-mediated injury, Arch Immunol Ther Exp (Warsz), 3, 213 Frei, 1989, Ascorbate is an outstanding antioxidant in human blood plasma, 86, 6377 Wefers, 1988, The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E, Eur J Biochem, 2, 353, 10.1111/j.1432-1033.1988.tb14105.x Smit, 1990, Inhibition of mitogen-activated prolif-eration of human lymphocytes by hypochlorous acid in vitro: protection and reversal by ascorbate and cysteine, Agents Actions, 3, 338, 10.1007/BF01966297 Hornig, 1998, Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure, Circulation, 4, 363, 10.1161/01.CIR.97.4.363 Anderson, 1988, Ascorbic acid neutralizes reactive oxidants released by hyperactive phagocytes from cigarette smokers, Lung, 1, 149, 10.1007/BF02714043 Jain, 1985, Reduced levels of plasma ascorbic acid (vitamin C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in vivo, Clin Chim Acta, 2–3, 257, 10.1016/0009-8981(85)90339-0 Riemersma, 1989, Low plasma vitamins E C. Increased risk of angina in Scottish men, Ann NY Acad Sci, 29, 291, 10.1111/j.1749-6632.1989.tb14928.x Tribble, 1993, Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke, Am J Clin Nutr, 6, 886, 10.1093/ajcn/58.6.886 Parinandi, 1990, Peroxidative modification of phospholipids in myocardial membranes, Arch Biochem Biophys, 1, 45, 10.1016/0003-9861(90)90516-2 Sadrzadeh, 1988, Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate, J Clin Invest, 5, 1510, 10.1172/JCI113759 Blumberg, 1993, Considerations of the scientific substantiation for antioxidant vitamins and beta-carotene in disease prevention, Am J Clin Nutr, 6 Suppl, 1521 Krinsky, 1989, Antioxidant functions of carotenoids, Free Rad Biol Med, 6, 617, 10.1016/0891-5849(89)90143-3 Ciaccio, 1993, Vitamin A inhibits doxorubicin-induced mem-brane peroxidation in rat tissues in vivo, Arch Biochem Biophys, 1, 103, 10.1006/abbi.1993.1186 Livrea, 1995, Contribution of vitamin A to the oxidation resistance of human low density lipoproteins, Free Radic Biol Med, 3, 401, 10.1016/0891-5849(94)00151-9 Helen, 1997, Effect of vitamin A supplementation on cigarette smoke —induced lipid peroxidation, Vet Hum Toxicol, 1, 18 Tesoriere, 1996, Synergistic interactions between vitamin A and vitamin E against lipid peroxidation in phosphatidylcholine liposomes, Arch Biochem Biophys, 1, 57, 10.1006/abbi.1996.0046 Goode, 1994, Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation, Hepatology, 2, 354, 10.1002/hep.1840190213 Honkanen, 1990, Serum cholesterol and vitamins A and E in juvenile chronic arthritis, Clin Exp Rheumatol, 2, 187 Handelman, 1996, Destruction of toco-pherols carotenoids, and retinol in human plasma by cigarette smoke, Am J Clin Nutr, 4, 559, 10.1093/ajcn/63.4.559 Kim, 1996, Serum levels of antioxidant vitamins in relation to coronary artery disease: a case control study of Koreans, Biomed Environ Sci, 2–3, 229 Pamuk, 1994, Effect of smoking on serum nutrient concentrations in African-American women, Am J Clin Nutr, 4, 891, 10.1093/ajcn/59.4.891 Pool Zobel, 1997, Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoidrich foods, Carcinogenesis, 9, 1847, 10.1093/carcin/18.9.1847 Pung, 1988, Betacarotene and canthaxanthin inhibit chemically-and physi-cally-induced neoplastic transformation in 10T1/2 cells, Car-cinogenesis, 9, 1533, 10.1093/carcin/9.9.1533 Palozza, 1998, Prooxidant actions of carotenoids in biologic systems, Nutr Rev, 9, 257 Waterhouse, 1995, Wine and heart disease, Chem Ind, 3, 338 Imai, 1995, Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases, Br Med J, 310, 693, 10.1136/bmj.310.6981.693 Homma, 1992, A strategy for discovering biologically active com-pounds with high probability in Chinese herb remedies: an application of Saibokuto in bronchial asthma, Ann Biochem, 202, 179, 10.1016/0003-2697(92)90225-V Robak, 1988, Flavonoids are scavengers of superoxide anions, Biochem Pharmacol, 37, 837, 10.1016/0006-2952(88)90169-4 Husain, 1987, Hydroxyl radical scavenging activity of flavonoids, Phytochemistry, 26, 126 Middleton, 1993, The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer Hertog, 1993, Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study, Lancet, 342, 1007, 10.1016/0140-6736(93)92876-U Keli, 1996, Dietary flavonoids, antioxidant vitamins and incidence of stroke, Arch Intern Med, 156, 637, 10.1001/archinte.156.6.637 Middleton, 1996, Biological properties of plant flavonoids: an overview, Int J Pharmacognosy, 34, 127 Muller, 1992, Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection, Free Rad Biol Med, 13, 651, 10.1016/0891-5849(92)90039-J Brinkworth, 1992, Flavones are inhibitors of HIV-1 proteinase, Biochem Biophys Res Commun, 188, 631, 10.1016/0006-291X(92)91103-W Tapiero, 1996, Increased glutathione expression in cells induced by Crassostrea gigas extract (JCOE), Biomed Pharmacother, 50, 149, 10.1016/0753-3322(96)85289-9 Gate, 1998, Impact of dietary supplement of Crassostrea gigas extract (JCOE) on glutathione levels and glutathione S-transferase activity in rat tissues, In vivo, 12, 299 Edeas, 1996, Protective effect of Crassostrea gigas extract against oxidative stress in human endothelial and red blood cells, Cell Pharmacol, 3, 337 Lampidis, 1996, Effects of Crassostrea gigas extract (JCOE) on cardiac cell function in vitro: antiarrhythmic activity, Cell Pharmacol, 3, 241 Tapiero, 1998, The antioxidant effects of Crassostrea gigas extract (JCOE) in human volunteers, In vivo, 12, 305 Archer, 1985, The chemotherapy of schistosomiasis, Annu Rev Pharmacol Toxicol, 25, 485, 10.1146/annurev.pa.25.040185.002413 Ansher, 1986, Biochemical effects of dithiolthiones, Food Chem Toxicol, 24, 405, 10.1016/0278-6915(86)90205-X Roebuck, 1991, Protection against Aflatoxin B1-induced hepa-tocarcinogenesis in F344 rats by 5- (2-pyrazinyl) -4-methyl-1,2-dithiole-3-thione (Oltipraz): predictive role for short-term molecular dosimetry, Cancer Res, 51, 5501 Rao, 1991, Effect of oltipraz (5- (2-pyrazinyl) -4-methyl-1, 2-dithiol-3-thione) on azoxymethane-induced biochemical changes related to early colon carcinogenesis in male F344 rats, 1, 77 Morse, 1995, Failure of dietary oltipraz to inhibit benzoapyrene-induced lung tumorigenesis in strain a mice, Cancer Lett, 1, 133, 10.1016/0304-3835(95)03730-K Nare, 1992, Induction of glutathione S-transferase isoenzymes in mouse liver by 5- (2-pyrazynl) -4-methyl-1, 2-dithiole-3-thione (oltipraz), Biochem Pharmacol, 4, 873, 10.1016/0006-2952(92)90255-H Langoust, 1996, A comparison of the effect of inducers on the expression of glutathione-S-transferases in the liver of the intact rat and in hepatocytes in primary culture, Hepatology, 4, 881, 10.1002/hep.510230432 Langoust, 1997, Effects of administration of the chemoprotective agent oltipraz on C YP1A and CYP2B in rat liver and rat hepatocytes in culture, Carcinogenesis, 7, 1343, 10.1093/carcin/18.7.1343 Antras Ferry, 1997, Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes, Carcinogenesis, 11, 2113, 10.1093/carcin/18.11.2113 Van Lieshout, 1998, Effects of dietary anticarcinogens on rat gastrointestinal glutathione peroxidase activity, Oncol Rep, 4, 959 Ali, 1991, Lipid peroxidation, glutathione and ascorbic acid concentrations in tissues of mice treated with oltipraz: influence of cysteine and olive oil pretreatment, Gen Pharmacol, 5, 985, 10.1016/0306-3623(91)90242-X Proschaska, 1993, Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication, 9, 3953